# Columbia  Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit

> **NIH NIH UM1** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2020 · $899,977

## Abstract

Project Summary
The SARS-CoV-2 pandemic has presented the field of infectious diseases and the clinical trials networks with
a number of challenges and opportunities. This Administrative Supplement request is being submitted for the
parent grant, the Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit (Columbia
Partnership Clinical Trials Unit, grant # 5UM1AI069470). The Columbia Partnership CTU encompasses four
Clinical Research Sites (CRSs) and one protocol-specific CRS aligned with three DAIDS-sponsored networks,
but this request is focused exclusively to support a crucial activity, the efficient and rapid expansion of SARS-
CoV-2 serological and molecular testing in diverse communities served by three of the four CRSs: The
Columbia P&S CRS, Harlem Prevention Center CRS and Bronx Prevention Center CRS. Each of the CRSs, by
virtue of their location in areas highly impacted by COVID-19 disease, relationships with local communities,
clinical and scientific expertise of investigators is in a unique position to not only expand testing, but do so by
using innovative strategies and among populations at greatest risk of the disease. The specific aims of this
supplement request are: (1) To leverage the existing clinical, laboratory and administrative infrastructure of the
Columbia Partnership CTU to efficiently and rapidly scale-up for SARS-CoV-2 testing activities; specifically to
help scale up testing in response to the growing need to provide clinical testing to diverse communities heavily
and disproportionately impacted by COVDI-19; and to prepare for upcoming clinical trials investigating
therapeutic and preventive interventions for COVID-19 disease. (2) To build on the existing community
engagement infrastructure to implement innovative methods to engage local communities and stakeholders
around SARS-CoV-2 testing and research efforts and to develop a suite of educational materials in support of
COVID-19 studies.

## Key facts

- **NIH application ID:** 10169016
- **Project number:** 3UM1AI069470-14S1
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** WAFAA M. EL-SADR
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $899,977
- **Award type:** 3
- **Project period:** 2020-06-10 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10169016

## Citation

> US National Institutes of Health, RePORTER application 10169016, Columbia  Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit (3UM1AI069470-14S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10169016. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*